A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

Clinical trial NCT05512819 · COMPLETED

Trial details

NCT number: NCT05512819
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2022-09-16
Primary completion: 2025-09-20
Enrollment: 541

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.